Table II.

Comparison of Ki-67 result and final diagnosis according to HPV infection status.

		Final diagnosis, n (%)
HPV status	Ki-67 score	HSIL	LSIL	NILM	P-value
HR (n=71)	0	0 (0.0)	16 (22.5)	1 (1.4)	<0.001
	1	3 (4.2)	9 (12.6)	0 (0.0)
	2	14 (19.7)	2 (2.8)	0 (0.0)
	3	26 (36.6)	0 (0.0)	0 (0.0)
LR (n=6)	0	0 (0.0)	2 (33.3)	0 (0.0)	<0.001
	1	1 (16.6)	1 (16.6)	0 (0.0)
	2	0 (0.0)	2 (33.3)	0 (0.0)
	3	0 (0.0)	0 (0.0)	0 (0.0)
N (n=26)	0	0 (0.0)	10 (38.4)	2 (7.7)	<0.001
	1	0 (0.0)	2 (7.7)	0 (0.0)
	2	7 (26.9)	1 (3.8)	0 (0.0)
	3	1 (3.8)	1 (3.8)	0 (0.0)
Total (n=103)	0	0 (0.0)	28 (27.2)	3 (2.9)
	1	4 (3.9)	14 (13.6)	0 (0.0)
	2	21 (20.3)	5 (4.8)	0 (0.0)
	3	27 (26.2)	1 (0.9)	0 (0.0)

HPV, human papilloma virus; HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion; NILM, negative for intraepithelial lesion or malignancy; HR, high-risk; LR, low-risk; N, negative.